Sjs Investment Consulting Inc. Harrow Health, Inc. Transaction History
Sjs Investment Consulting Inc.
- $534 Million
- Q1 2025
A detailed history of Sjs Investment Consulting Inc. transactions in Harrow Health, Inc. stock. As of the latest transaction made, Sjs Investment Consulting Inc. holds 3,073 shares of HROW stock, worth $94,248. This represents 0.02% of its overall portfolio holdings.
Number of Shares
3,073
Previous 3,073
-0.0%
Holding current value
$94,248
Previous $103,000
21.36%
% of portfolio
0.02%
Previous 0.02%
Shares
1 transactions
Others Institutions Holding HROW
# of Institutions
176Shares Held
21.1MCall Options Held
330KPut Options Held
670K-
Opaleye Management Inc. Boston, MA3.96MShares$121 Million28.93% of portfolio
-
Black Rock Inc. New York, NY2.15MShares$65.9 Million0.0% of portfolio
-
Private Capital Management, LLC Naples, FL1.89MShares$58 Million6.53% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.87MShares$57.2 Million0.0% of portfolio
-
Braidwell LP Stamford, CT957KShares$29.3 Million1.56% of portfolio
About HARROW HEALTH, INC.
- Ticker HROW
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 27,070,000
- Market Cap $830M
- Description
- Harrow Health, Inc. operates as an ophthalmic-focused healthcare company. The company owns ImprimisRx, an ophthalmology outsourcing and pharmaceutical compounding business; and DEXYCU for the treatment of post-operative inflammation. The company also holds equity interests in Surface Ophthalmics, Inc., a clinical-stage pharmaceutical company tha...